Stock Scorecard
Stock Summary for Laboratory Corp Of America Holdings (LH) - $258.06 as of 12/9/2025 8:47:34 PM EST
Total Score
15 out of 30
Safety Score
56 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for LH
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for LH
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for LH
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for LH
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for LH (56 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 10 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 7 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for LH
Financial Details for LH
Company Overview |
|
|---|---|
| Ticker | LH |
| Company Name | Laboratory Corp Of America Holdings |
| Country | USA |
| Description | Laboratory Corporation of America Holdings (Labcorp), headquartered in Burlington, North Carolina, is a leading global life sciences company that provides comprehensive laboratory services and solutions essential for healthcare advancement. With a robust network of 36 clinical laboratories across the United States, Labcorp delivers a wide array of diagnostic testing and drug development services, playing a pivotal role in enhancing patient care. By harnessing cutting-edge technology and sophisticated data analytics, the company is at the forefront of personalized medicine, positioning itself as an indispensable partner in improving health outcomes worldwide. |
| Sector Name | HEALTHCARE |
| Industry Name | DIAGNOSTICS & RESEARCH |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 2/5/2026 |
Stock Price History |
|
| Last Day Price | 258.06 |
| Price 4 Years Ago | 257.79 |
| Last Day Price Updated | 12/9/2025 8:47:34 PM EST |
| Last Day Volume | 500,159 |
| Average Daily Volume | 1,054,884 |
| 52-Week High | 292.94 |
| 52-Week Low | 207.68 |
| Last Price to 52 Week Low | 24.26% |
Valuation Measures |
|
| Trailing PE | 25.38 |
| Industry PE | 36.73 |
| Sector PE | 52.63 |
| 5-Year Average PE | 14.61 |
| Free Cash Flow Ratio | 35.79 |
| Industry Free Cash Flow Ratio | 68.08 |
| Sector Free Cash Flow Ratio | 28.62 |
| Current Ratio Most Recent Quarter | 1.55 |
| Total Cash Per Share | 7.21 |
| Book Value Per Share Most Recent Quarter | 104.78 |
| Price to Book Ratio | 2.46 |
| Industry Price to Book Ratio | 231.85 |
| Sector Price to Book Ratio | 33.49 |
| Price to Sales Ratio Twelve Trailing Months | 1.56 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.69 |
| Sector Price to Sales Ratio Twelve Trailing Months | 16.13 |
| Analyst Buy Ratings | 12 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 82,900,000 |
| Market Capitalization | 21,393,174,000 |
| Institutional Ownership | 97.81% |
Dividends |
|
| Ex-Dividend Date | 11/26/2025 |
| Previous Dividend Amount | 0.7200 |
| Current Dividend Amount | 0.7200 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 2.88 |
| Trailing Annual Dividend Yield | 1.12% |
| Forward Annual Dividend Rate | 2.88 |
| Forward Annual Dividend Yield | 1.12% |
| 5-Year Dividend Payments Count | 15 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 31.95% |
| All-Time Dividend Growth Rate Percentage | 31.95% |
| Dividend Payout Ratio | 28.29% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 56.00% |
| Annual Earnings Growth | 78.47% |
| Reported EPS 12 Trailing Months | 10.18 |
| Reported EPS Past Year | 12.37 |
| Reported EPS Prior Year | 14.57 |
| Net Income Twelve Trailing Months | 855,200,000 |
| Net Income Past Year | 746,000,000 |
| Net Income Prior Year | 418,000,000 |
| Quarterly Revenue Growth YOY | 8.60% |
| 5-Year Revenue Growth | 2.40% |
| Operating Margin Twelve Trailing Months | 11.30% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 598,100,000 |
| Total Cash Past Year | 1,518,700,000 |
| Total Cash Prior Year | 536,800,000 |
| Net Cash Position Most Recent Quarter | -4,484,400,000 |
| Net Cash Position Past Year | -3,812,500,000 |
| Long Term Debt Past Year | 5,331,200,000 |
| Long Term Debt Prior Year | 4,054,700,000 |
| Total Debt Most Recent Quarter | 5,082,500,000 |
| Equity to Debt Ratio Past Year | 0.60 |
| Equity to Debt Ratio Most Recent Quarter | 0.63 |
| Total Stockholder Equity Past Year | 8,052,200,000 |
| Total Stockholder Equity Prior Year | 7,875,000,000 |
| Total Stockholder Equity Most Recent Quarter | 8,696,900,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,380,800,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 16.66 |
| Free Cash Flow Past Year | 1,095,900,000 |
| Free Cash Flow Prior Year | 874,100,000 |
Options |
|
| Put/Call Ratio | 0.25 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.74 |
| MACD Signal | -0.69 |
| 20-Day Bollinger Lower Band | 251.24 |
| 20-Day Bollinger Middle Band | 269.99 |
| 20-Day Bollinger Upper Band | 288.74 |
| Beta | 0.96 |
| RSI | 40.43 |
| 50-Day SMA | 252.70 |
| 150-Day SMA | 222.02 |
| 200-Day SMA | 216.70 |
System |
|
| Modified | 12/9/2025 3:40:05 AM EST |